HRH3: A GPCR-Connected Protein with Promising Therapeutic Applications

Target Name: HRH3

NCBI ID: G11255

HRH3

HRH3: A GPCR-Connected Protein with Promising Therapeutic Applications

HRH3 (HH3R) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a critical role in cellular signaling. While the exact function of HRH3 is not yet well understood, it is known to be involved in a wide range of physiological processes, including cardiovascular function, neurotransmission, and inflammation. As a result, HRH3 has emerged as a potential drug target for a variety of therapeutic applications.

The GPCR family consists of several different subfamilies, each of which is characterized by a unique combination of gene and protein interactions. The HRH3 gene is located in the fourth subfamily, which is characterized by a unique combination of gene and protein interactions that are specific to this subfamily.

The HRH3 protein is a member of the HRH subfamily, which is characterized by the presence of the protein in the brain and kidneys. It is expressed in various tissues of the body, including the brain, heart, and kidneys. HRH3 is known to play a critical role in neurotransmission, as it is involved in the regulation of neurotransmitter release from neurons.

In addition to its role in neurotransmission, HRH3 is also involved in cardiovascular function. It has been shown to be involved in the regulation of heart rate and blood pressure, as well as the development of cardiovascular disease.

HRH3 is also involved in the regulation of inflammation. It has been shown to play a critical role in the regulation of immune cell function, as well as the development of inflammatory diseases.

Despite the many promising studies on HRH3, much is still not understood about its function and potential as a drug target. However, its involvement in a wide range of physiological processes makes it a promising target for therapeutic applications.

Conclusion
HRH3 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the G-protein-coupled receptor (GPCR) family and is involved in a wide range of physiological processes, including neurotransmission, cardiovascular function, and inflammation. As a result, HRH3 has emerged as a promising drug target for a variety of therapeutic applications. Further research is needed to fully understand its function and potential as a drug target.

Protein Name: Histamine Receptor H3

Functions: The H3 subclass of histamine receptors could mediate the histamine signals in CNS and peripheral nervous system. Signals through the inhibition of adenylate cyclase and displays high constitutive activity (spontaneous activity in the absence of agonist). Agonist stimulation of isoform 3 neither modified adenylate cyclase activity nor induced intracellular calcium mobilization

The "HRH3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HRH3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets